Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Salient Pharma ApS
APS
Active
Reklamebeskyttelse
CVR 36900709
Naverland 22, 2600
Glostrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 11 years old
1 employees
www.salientpharma.com
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Salient Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
0M
+100%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-485
-259
-126
-233
-124
Staff expenses
-403
-2
-0
-0
-0
EBITDA
-888
-261
-126
-233
-124
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-888
-261
-126
-233
-124
Net financials
-14
-40
-63
-72
-78
Profit before tax
-902
-301
-188
-305
-202
Tax
-0
-0
-0
-0
-0
Net profit
-902
-301
-188
-305
-202
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
45
55
58
21
19
Equity
-492
-793
-981
-1.161
-1.126
Long-term debt
0
0
0
0
0
Short-term debt
537
848
1.039
1.181
1.145
Total debt
537
848
1.039
1.181
1.145
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-12437200.0%
This company
2020
2024
Soliditetsgrad
-5917.4%
This company
38.2%
Market median
-15591% vs market
2020
2024
Egenkapitalforrentning
-20218000.0%
This company
18.4%
Market median
-109880535% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
-20218000.0%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
-6.54×
This company
2020
2024
Gæld/egenkapital
1.02×
This company
0.62×
Market median
-65% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Salient Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
